Improved control of endemic foot-and-mouth disease by development of virus like particle vaccines
In plain English
AI plain-English summaryFoot-and-mouth disease vaccines made from killed virus require high-containment facilities and protect livestock for only a short time against a narrow range of viral strains. This project aims to replace those vaccines with synthetic virus-like particles grown in insect cells—a safer, cheaper, and more adaptable platform. The problem is that current vaccines are a major constraint on global livestock trade. Outbreaks cause enormous economic losses, but the vaccines themselves are expensive to produce and offer limited, short-lived immunity. Farmers in endemic regions often cannot afford repeated vaccination, leaving herds vulnerable. If successful, this new platform would allow researchers to engineer the viral capsid—the protein shell that triggers immunity—to stimulate longer-lasting antibody responses and protect against many viral strains at once. That could reduce the frequency of vaccination, lower costs, and make international trade in livestock products less risky. The work is applied vaccine development with a clear practical endpoint: better control of a devastating animal disease in the field.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Strategic Award - InnovationsPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know